The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Episode 1 November 30, 2021 00:20:49
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination
COR2ED Medical Education
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Nov 30 2021 | 00:20:49

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of Graz, Austria, discuss the role of VEGFR-TKIs in the treatment of advanced renal cell carcinoma (RCC) alone or in combination with immunotherapy.

In this podcast, by COR2ED Medical Education, the two experts discuss key trials (CHECKMATE 214, KEYNOTE 426, CHECKMATE 9ER and CLEAR) which have led to recent updates to the ESMO and EAU treatment guidelines for RCC. Combination treatment with either VEGFR targeted therapy plus a PD-1 or CTLA-4 inhibitor in the first-line setting is discussed as well as VEGFR-TKI monotherapy options at the time of disease progression.

They also focus on how to manage treatment toxicity whilst trying to optimise treatment outcomes and preserving patients’ quality of life as well as the use of biomarkers and risk stratification models.

Other Episodes

Episode 1

December 14, 2022 00:19:51
Episode Cover

Clinical implementation of targeted and immunotherapies for advanced RCC

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of...

Listen

Episode 15

July 13, 2023 00:27:27
Episode Cover

Non-metastatic gastric and GEJ cancers: clinical case discussions ep.1

COR2ED Medical Education: This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth...

Listen

Episode 2

September 30, 2021 00:13:19
Episode Cover

Highlights from ILCA and ESMO 2021 in HCC

Professor Matthias Pinter, medical hepatologist from the medical University of Vienna in Austria shares some insights from key abstracts and topics discussed at ILCA...

Listen